Candesartan-M (deethyl-)
Compound with spectra: 2 MS (LC)
| SpectraBase Compound ID | E1wOxDMMxXs |
|---|---|
| InChI | InChI=1S/C22H16N6O3/c29-21(30)17-6-3-7-18-19(17)28(22(31)23-18)12-13-8-10-14(11-9-13)15-4-1-2-5-16(15)20-24-26-27-25-20/h1-11H,12H2,(H,23,31)(H,29,30)(H,24,25,26,27) |
| InChIKey | KLCPKPIDOPBIQW-UHFFFAOYSA-N |
| Mol Weight | 412.41 g/mol |
| Molecular Formula | C22H16N6O3 |
| Exact Mass | 412.128388 g/mol |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Meyer/Helfer/Weber c/o Saarland University Homburg/Saar |
| Technique | HCD |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Meyer/Helfer/Weber c/o Saarland University Homburg/Saar |
| Technique | HCD |
- Candesartan-M (deethyl-)_neg
Candesartan-M (glucuronide) MS3_1
methyl 3-[(4-bromophenyl)methyl]-2-ethoxy-benzimidazole-4-carboxylate
Olmesartan artifact (-H2O) MS2
2-Butyl-6-ethoxy-5-phenethyl-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-pyrimidin-4-one
Imidazo[4,5,1-jk][1,4]benzodiazepine, 4,5-dihydro-2-methyl-7-phenyl-
2-Butyl-6-methoxy-5-phenethyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-3H-pyrimidin-4-one
4'-{[5-(2-Butyl-3-(3-methylphenyl))-2,1,3,4-1H-thiatriazol-2-on-1-yl]methyl}biphenyl-2-tetrazole
1H-1,3-Benzimidazole-2-methanol, 1-(1-naphthalenylmethyl)-.alpha.-phenyl-
N-[(2'"-Pyridyl)methyl]-[1"-(p-chlorobenzyl)-5"-acetoxy-1H-benzimidazol-2"-yl]-benzamide
Methyl 1-(4-chlorobenzyl)-2-(4-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-1H-benzo[d]imidazole-5-carboxylate
This compound is available in the following databases:
Maurer, Meyer, Helfer, Weber: LC-HR-MS & MS Library of Drugs, Poisons, and Their Metabolites
Author: Hans H. Maurer, Markus Meyer, Andreas G. Helfer, Armin A. Weber
Developed by toxicologist Hans H. Maurer and his team, the Maurer/Meyer/Helfer/Weber LC-HR-MS/MS Library of Drugs, Poisons, and Their Metabolites consists of spectra for parent drugs or poisons, and their metabolites or artifacts, in various compound classification groups. This metabolite-based library helps minimize the risk of false negative LC-MS results. Learn more.